Lora Alvey Perry, MD
Obstetrics & Gynecology · Evansville, INNPI 1497926919
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $7,875 of the $8,827 with a category attached, or 89.2%. 9 manufacturers reported payments, led by Organon at 47.0% of the total. Reporting peaked in 2022 at $4,188 and has fallen 96.7% since, to $140 in 2025. Among obstetrics & gynecology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 22 payments — averaging $401.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$4K
- Merck$4K
- Gynesonics, Inc.$140
- AbbVie$119
- Pfizer$117
- Astellas Pharma US Inc$88
- plus $91 from 3 others
What the payments were for
- Speaking & faculty fees$7,87589%
- Travel & lodging$3364%
- Food & beverage$6167%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 5 | $4,147 |
| Merck | 7 | $4,125 |
| Gynesonics, Inc. | 1 | $140 |
| AbbVie | 3 | $119 |
| Pfizer | 2 | $117 |
| Astellas Pharma US Inc | 1 | $88 |
| Covidien LP | 1 | $46 |
| Applied Medical Resources Corporation | 1 | $27 |
| Duchesnay USA Incorporated | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,827 in reported general payments places this provider in the 95th percentile of 743 obstetrics & gynecology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 41 | $1,647 |
| Clobetasol Propionate | 35 | $780 |
| Alendronate Sodium | 63 | $330 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 26 | $212 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Evansville
- Ashley ScottFort Wayne$124K
- Candace WestgateIndianapolis$123K
- Keith RamseyLake Station$116K
- Stefanie FloraCarmel$106K
- Lori DavidsonGreenwood$54K
- Julius Ellisla Porte$53K
- Emmary ButlerWinchester$45K
- Enrique InfanteElkhart$41K
- Paul MorrisonNewburgh$38K
- Joseph ShinnLafayette$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.